Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 9.01 · 8-K

Plexus Corp.

PLXSNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 18, 2026, Dean A. Foate, Chair of the Board of Directors (the “Board”) of Plexus Corp.…

Filed Nov 19, 2026Accepted Nov 19, 2026, 4:28 PM ESTCIK 785786Accession 0000785786-26-000068
Share

Company context

At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.

Current securities

Recent company filings

  1. 10-K filingNov 19, 2026
  2. Results of Operations and Financial ConditionOct 28, 2026
  3. Other EventsAug 24, 2026
  4. 144 filingAug 19, 2026
  5. 4 filingAug 13, 2026

Registered securities in this filing

PLEXUS CORP. · 8-K · Filed 2026-11-19

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.01 par value

Symbol
PLXS
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: c-1

Dimensions: Not supplied

Accession 000078578626000068 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 18, 2026, Dean A. Foate, Chair of the Board of Directors (the “Board”) of Plexus Corp. (the “Company”), notified the Company of his decision not to stand for reelection to the Board at the Company’s 2027 Annual Meeting of Shareholders (the “2027 Annual Meeting”). Mr. Foate will continue to serve as a director and Chair of the Board until the conclusion of the 2027 Annual Meeting, at which time his service on the Board will end. Mr. Foate’s decision is a personal one and is not the result of any disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices. The Board has selected Michael V. Schrock, a current member of the Board, to succeed Mr. Foate as Chair of the Board, effective upon the conclusion of the 2027 Annual Meeting, subject to Michael V. Schrock’s reelection to the Board by the Company’s shareholders at the 2027 Annual Meeting. In connection with Mr. Foate’s decision not to stand for reelection, the Board has approved a reduction in the size of the Board from ten to nine directors, effective as of the conclusion of the 2027 Annual Meeting. The Board thanks Mr. Foate for his many years of dedicated service and leadership to the Company, including as Chief Executive Officer and, subsequently, as a director and Chair of the Board.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.